Our Mission
The Chicago MS Alliance is a coalition of neuroimmunologists working to improve care for individuals with MS and related conditions across the Chicagoland region. Through collaboration, education, and advocacy, we aim to drive equity and innovation in MS care.
Our Story
The Chicago MS Alliance was founded by a group of neuroimmunologists who saw a clear need: despite world-class institutions in the region, MS care remained fragmented, and many patients lacked access to coordinated, comprehensive support.
What began as a shared concern among colleagues grew into a collaborative network focused on improving outcomes for people living with multiple sclerosis and related neuroimmunologic conditions. Our goal is simple but ambitious — to break down silos, bridge gaps in care, and drive meaningful change through research, education, and advocacy.
By uniting experts across institutions, we’re building a stronger infrastructure for MS care in Chicagoland — one that centers patients, uplifts health care professionals, and pushes the field forward.
Through strategic partnerships, educational initiatives, and advocacy efforts, the Chicago MS Alliance is committed to transforming the landscape of MS care—ensuring that every individual living with MS in our region has access to the best possible support, treatments, and opportunities for a better future.
Our Key Initiatives
The Chicago MS Alliance is dedicated to improving the lives of people living with multiple sclerosis (MS) and related neuroimmunologic conditions. Through coordinated efforts in research, education, and patient advocacy, we focus on four core initiatives that drive meaningful impact across the Chicagoland region.
MS & Neuroimmunology Specialist Network
Connecting top neuroimmunologists across Chicagoland to expand access to expert, multidisciplinary care.
Integrated Research & Clinical Trials Network
Expanding access to cutting-edge research and clinical trials through a connected network of leading MS centers.
Healthcare Professional Education & Training
Delivering expert-led training to equip health care professionals with the latest in MS and neuroimmunology care.
Patient & Community Education
Providing patients, families, and caregivers with the knowledge and tools to navigate MS with confidence.
MEET THE TEAM
BOARD MEMBERS
Meet the board members of the Chicago MS Alliance, leaders in neuroimmunology dedicated to advancing research, equity, and collaboration across the region. Click each profile to read the full bio.
-
William L. Conte, MD, MS
PRESIDENT & FOUNDER
Dr. William L. Conte is a leading MS expert and founder of the Chicago MS Alliance, driving innovation, equity, and collaboration in neuroimmunology care.
METHODIST HOSPITALS COMPREHENSIVE MS CENTER, MERRILLVILLE, IN
-
Allison Osen, MD
VICE PRESIDENT
Dr. Allison Osen is a neuroimmunologist at Rush with a focus on MS, health equity, and brain health—driving research and access across Chicagoland through the MS Alliance.
RUSH UNIVERSITY, CHICAGO, IL
-
Veronica Cipriani, MD
Dr. Veronica Cipriani leads the MS Clinic at The University of Chicago, where she champions equitable care, medical education, and cross-center collaboration through the MS Alliance.
THE UNIVERSITY OF CHICAGO, CHICAGO, IL
-
Carolyn Goldschmidt, DO
Dr. Carolyn Goldschmidt is a neurologist at Endeavor Health focused on MS care, research, and advocacy. She serves on the Chicago MS Alliance board to help expand access and support for patients.
ENDEAVOR HEALTH NORTHSHORE, EVANSTON, IL
-
Edith Graham, MD
Dr. Graham is a neurologist at Northwestern with a focus on women’s neurology and MS—advancing care, research, and collaboration across the Chicagoland MS community.
NORTHWESTERN UNIVERSITY, CHICAGO, IL
-
Augusto Miravalle, MD
Dr. Augusto Miravalle is a global leader in MS care and brain health, heading Neuroimmunology at Rush and shaping the future of research, education, and equity in MS.
RUSH UNIVERSITY, CHICAGO, IL
OUR PARTNERS
The Chicago MS Alliance is a nonprofit 501(c)(3) advocacy organization. We are generously supported by our pharmaceutical industry sponsors through educational grants.
